OpalGenix, Inc.
Carmel, IN · Biotech · Private
A genetic risk prediction tool that analyzes patient genotypes to identify pregnant women with opioid use disorder at high risk for relapse and predict neonatal opioid withdrawal syndrome severity
- Grants
- $1.7M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Avoiding Adverse Opioid Outcomes with Proactive Precision Care | $374,447 | |
| Federal grant | Department of Health and Human Services · Phase I · Avoiding Adverse Opioid Outcomes with Proactive Precision Care | $55,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Reducing Opioid Use and Adverse Effects through Proactive Precision Pain Management Following Spine Surgery | $326,500 | |
| Federal grant | Department of Health and Human Services · Phase I · Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy | $325,239 | |
| Federal grant | Department of Health and Human Services · Phase I · Improving Analgesic Effectiveness and Safety with Proactive Precision Pain Management in Thoracic Surgical Patients with Lung Lesions | $644,425 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2247 | NOUR HEART, INC. | — | — |
| 2248 | NAPROGENIX, INC. | — | — |
| 2249 | BRIDGENE BIOSCIENCES, INC. | — | — |
| 2250 | OpalGenix, Inc. | — | — |
| 2251 | ProDa BioTech L.L.C. | — | — |
| 2252 | AUMENTA BIOSCIENCES, INC. | — | — |
| 2253 | General Reasoning, Inc. | — | $11M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.